National Lipid Association Annual Summary of Clinical Lipidology 2016

被引：94

作者：

Bays, Harold E. ^{[1
]}

Jones, Peter H. ^{[2
]}

Orringer, Carl E. ^{[3
]}

Brown, W. Virgil ^{[4
]}

Jacobson, Terry A. ^{[5
]}

机构：

[1] Louisville Metab & Atherosclerosis Res Ctr, 3288 Illinois Ave, Louisville, KY 40213 USA

[2] Baylor Coll Med, Houston, TX 77030 USA

[3] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA

[4] Emory Univ, Sch Med, Atlanta, GA USA

[5] Emory Univ, Dept Med, Atlanta, GA 30322 USA

来源：

JOURNAL OF CLINICAL LIPIDOLOGY | 2016年 / 10卷 / 01期

关键词：

Clinical Lipidology; Dyslipidemia; National Lipid Association; Annual Summary; Cholesterol; Recommendations; Guidelines; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; PATIENT-CENTERED MANAGEMENT; EVALUATING ROSUVASTATIN JUPITER; CARDIOVASCULAR RISK PREDICTION; POLYCYSTIC-OVARY-SYNDROME; SUBTILISIN/KEXIN TYPE 9; C-REACTIVE PROTEIN; TASK-FORCE;

D O I：

10.1016/j.jacl.2015.08.002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The National Lipid Association (NLA) Annual Summary of Clinical Lipidology is a yearly updated summary of principles important to the patient-centered evaluation, management, and care of patients with dyslipidemia. This summary is intended to be a "living document," with future annual updates based on emerging science, clinical considerations, and new NLA Position, Consensus, and Scientific Statements, thus providing an ongoing resource that applies the latest in medical science towards the clinical management of patients with dyslipidemia. Topics include the NLA Recommendations for Patient-Centered Management of Dyslipidemia, genetics, Familial Hypercholesterolemia, secondary causes of dyslipidemia, biomarkers and advanced lipid testing, nutrition, physical activity, obesity, adiposopathy, metabolic syndrome, diabetes mellitus, lipid pharmacotherapy, lipid-altering drug interactions, lipoprotein apheresis, dyslipidemia management and treatment based upon age (children, adolescents, and older individuals), dyslipidemia considerations based upon race, ethnicity and gender, dyslipidemia and human immune virus infection, dyslipidemia and immune disorders, adherence strategies and collaborative care, and lipid-altering drugs in development. Hyperlinks direct the reader to sentinel online tables, charts, and figures relevant to lipidology, access to online atherosclerotic cardiovascular disease risk calculators, worldwide lipid guidelines, recommendations, and position/scientific statements, as well as links to online audio files, websites, slide shows, applications, continuing medical education opportunities, and patient information. (C) 2016 National Lipid Association. All rights reserved.

引用

页码：S1 / S43

页数：43

共 202 条

[81] Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia [J].

Hopkins, Paul N. ;

Toth, Peter P. ;

Ballantyne, Christie M. ;

Rader, Daniel J. .

JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (03) :S9-S17

[82] Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial [J].

Hovingh, G. Kees ;

Kastelein, John J. P. ;

van Deventer, Sander J. H. ;

Round, Patrick ;

Ford, John ;

Saleheen, Danish ;

Rader, Daniel J. ;

Brewer, H. Bryan ;

Barter, Philip J. .

LANCET, 2015, 386 (9992) :452-460

[83] PLASMA AND LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDE CONCENTRATIONS IN THE PIMA-INDIANS - DISTRIBUTIONS DIFFERING FROM THOSE OF CAUCASIANS [J].

HOWARD, BV ;

DAVIS, MP ;

PETTITT, DJ ;

KNOWLER, WC ;

BENNETT, PH .

CIRCULATION, 1983, 68 (04) :714-724

[84] Rising tide of cardiovascular disease in American Indians - The Strong Heart Study [J].

Howard, BV ;

Lee, ET ;

Cowan, LD ;

Devereux, RB ;

Galloway, JM ;

Go, OT ;

Howard, WJ ;

Rhoades, ER ;

Robbins, DC ;

Sievers, ML ;

Welty, TK .

CIRCULATION, 1999, 99 (18) :2389-2395

[85] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].

Hulley, S ;

Grady, D ;

Bush, T ;

Furberg, C ;

Herrington, D ;

Riggs, B ;

Vittinghoff, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613

[86] Prediction of Cardiovascular Death in Racial/Ethnic Minorities Using Framingham Risk Factors [J].

Hurley, Laura P. ;

Dickinson, L. Miriam ;

Estacio, Raymond O. ;

Steiner, John F. ;

Havranek, Edward P. .

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (02) :181-U125

[87] CORONARY HEART-DISEASE IN PIMA INDIANS - ELECTROCARDIOGRAPHIC FINDINGS AND POSTMORTEM EVIDENCE OF MYOCARDIAL-INFARCTION IN A POPULATION WITH A HIGH PREVALENCE OF DIABETES-MELLITUS [J].

INGELFINGER, JA ;

BENNETT, PH ;

LIEBOW, IM ;

MILLER, M .

DIABETES, 1976, 25 (07) :561-565

[88]

Ison H.E., 2014, GENEREVIEWS, P1993

[89] Management of Familial Hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia [J].

Ito, Matthew K. ;

McGowan, Mary P. ;

Moriarty, Patrick M. .

JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (03) :S38-S45

[90] National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1-Full Report [J].

Jacobson, Terry A. ;

Ito, Matthew K. ;

Maki, Kevin C. ;

Orringer, Carl E. ;

Bays, Harold E. ;

Jones, Peter H. ;

McKenney, James M. ;

Grundy, Scott M. ;

Gill, Edward A. ;

Wild, Robert A. ;

Wilson, Don P. ;

Brown, W. Virgil .

JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (02) :129-169

← 4 5 6 7 8 9 10 11 12 13 →